Phase Ib Study of XMT-1660 in Solid Tumors Likely to Express B7-H4
Ritesh Parajuli
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 49 Results
PhIb BI 764532 Given Monotherapy Administered by Repeated Intravenous Infusions in Pa w/Glioma DLL3
Daniela Bota
- OPEN TO ACCRUAL
Efficacy and safety study of frexalimab in adults with nonrelapsing secondary progressive MS.
Michael Sy
- OPEN TO ACCRUAL
PhI/IbVET3-TGI AdminisAlon&ComboW/PembroPtsW/AdvSolidTumor
Edward Uchio
- OPEN TO ACCRUAL
Efgartigimod PH20 SC (ARGX-113)
Tahseen Mozaffar
- OPEN TO ACCRUAL
Distal Ischemic Stroke Treatment
Radoslav Raychev
- OPEN TO ACCRUAL
RepurposingRiluzoleAugmentBrainDerivedNeuropathFactorLevel&CogFunc BreastCaPa ExpCa-Related CogImpai
Alexandre Chan
- OPEN TO ACCRUAL
Phase 3 study evaluating efficacy and safety of riliprubart versus IVIg in CIDP - VITALIZE
Jeffrey Mullen
- OPEN TO ACCRUAL
A Phase 3, double-blind, randomized, placebo-controlled study evaluating efficacy of SAR445088
Jeffrey Mullen
- OPEN TO ACCRUAL
PhIII TrialSingFractionStereotacticRadiosurgVSFractionatedSRS IntactBrainMets
Aaron Simon
- OPEN TO ACCRUAL
ph3 Telitacicept In Patients With Generalized Myastenia Gravis
Ali Habib
- OPEN TO ACCRUAL
BRT-DA01-501
Claire Henchcliffe
- OPEN TO ACCRUAL
Ph Ib RMC-6291 in Comb w/ RMC-6236 in Pts w/ Adv KRASG12C Mutated Solid Tumors
Zhaohui Ann Arter
- OPEN TO ACCRUAL
PhI/II DosEscalDosExpan&CohortExpanFMC376 Particip w/KRASG12C MutatLocalAdvUnresec orMetsSolidTu
Farshid Dayyani
- OPEN TO ACCRUAL
PhIStudySafetyPharmacokineticsEfficacy BA3182 Bispecific (EPCAM)/CD3 Antibody Pa w/AdvAdenocarcinoma
Jennifer Brooke Valerin
- OPEN TO ACCRUAL
Evaluate Satralizumab as Monotherapy or in Addition to Baseline Therapy in Patients with MOGAD
Michael Sy
- OPEN TO ACCRUAL
PhI/Ib FirstInHuman Investig SafeTolerabPharmBiologic&ClinicalActiv DF6215 Pa w/Adv Solid Tu
Jennifer Brooke Valerin
- OPEN TO ACCRUAL
PhI Study PolymeraseThetaInhibitor Novobiocin BRCAMutant&Other DNADamageRepair-Deficient SolidTumors
Jennifer Brooke Valerin
- OPEN TO ACCRUAL
LIBREXIA-STROKE
Jay Shah
- OPEN TO ACCRUAL
Ph II Subcutan Amivantamab in Pts w/ Adv or Metastat SolidTumors EGFR-mutated Non-Small Cell Lung Ca
Misako Nagasaka
- OPEN TO ACCRUAL